From the November progress report"The management team presented to a promising government agency that is currently conducting due diligence for an equity stake. In addition the scientific team has been in discussions with federal government officials who are reviewing BioMark’s activities that can qualify for funding in yearly 2017. All other discussions reported in the previous monthly progress are ongoing. The company is in continual communication with The Metabolomics Innovation Centre (TMIC) development team as both groups are anticipating early results of the specific signatures for breast cancer which if successful could increase its diagnostic assay pipeline. The company anticipates an update status report from its regulatory group on its current submission to Health Canada and whether there are other follow up studies needed to further establish a more substantive submission. The update is anticipated in a few weeks."
Looking like there is promising developments going on behind the scenes. News coming!